Comparison of bioavailability and phototoxicity of two oral preparations of 5-methoxypsoralen
Authors:
- 31 March 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 112 (4) , 469-473
Abstract
5-Methoxypsoralen (5-MOP) (Psoraderm 5) tablets obtained from France and 5-MOP micronized in capsule (manufactured in this pharmacy department) were administered to 7 psoriasis patients in a 1.2 mg/kg body wt dose schedule. Bioavailability and phototoxicity were compared. The maximum serum concentration and the area under the concentration curve were significantly higher (P < 0.01) after administration of the capsules, indicating higher bioavailability. No erythema developed in any of the patients after administration of the tablets, whereas with the capsules 4 of the patients developed erythema at the test site. The absence of erythema following the use of the tablets is probably due to the poor bioavailability of this preparation.Keywords
This publication has 6 references indexed in Scilit:
- Psoralen Phototoxicity: Correlation with Serum and Epidermal 8-Methoxypsoralen and 5-Methoxypsoralen in the Guinea PigScience, 1982
- Serum and urine concentrations of 5-methoxypsoralen after oral administrationBritish Journal of Dermatology, 1981
- 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasisBritish Journal of Dermatology, 1979
- Phototesting and dosimetry for photochemotherapyBritish Journal of Dermatology, 1977
- PHOTOCHEMOTHERAPY (PUVA) AND PSORIASIS: COMPARISON OF 8-MOP AND 8-MQP/5-MOPInternational Journal of Dermatology, 1976
- Part IV: Basic Considerations of the Psoralens: Relationship of Molecular Configuration to the Activity of Furocoumarins Which Increase the Cutaneous Responses Following Long Wave Ultraviolet Radiation11From the Division of Dermatology, University of Oregon Medical School, Portland, Oregon.Journal of Investigative Dermatology, 1959